SCIENTIFIC HUB

Follow the evidence.

106.818 articles found

Source record

Effect of the mGlu<sub>2</sub> receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmoset.

Shaqfah J, Bédard D, Nuara SG, Gourdon JC, Hamadjida A, Gaudette F, Beaudry F, Huot P.

Eur J Pharmacol · 2025-08-05

DOI: 10.1016/j.ejphar.2025.178031PMID: 40752762

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Synthesis and evaluation of novel 5-HT<sub>2A</sub> receptor inverse agonist with excellent in vivo antipsychotic efficacy and superior tissue distribution for treatment of Parkinson's disease psychosis.

Ma M, Du G, Wang W, Dai Y, Xu H, Wei Y, Yang H, Zhu X, Zhao M, Gao Y, Zhang J, Ye L, Tian J.

Eur J Med Chem · 2025-08-05

DOI: 10.1016/j.ejmech.2025.118044PMID: 40784305

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Mechanistic insights into ubiquinone Q10 in Parkinson's disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling.

Saadh MJ, Nazar Saeed T, Fawzi Al-Hussainy A, Kyada A, Ballal S, Kundlas M, Sabarivani A, Rizaev J, Ghalib Taher S, Alwan M, Jawad M, Mushtaq H.

Arch Physiol Biochem · 2025-08-05

DOI: 10.1080/13813455.2025.2541698PMID: 40762836

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.